Additional Information
Market: AIM
Sector: General Mining - Rare Earth Minerals
EPIC: NVTA
Latest Price: 4.83p  (0,00%)
52-week High: 176.00p
52-week Low: 4.68p
Market Cap: 5.78M
1 year chart
digital-look imported chart image
1 day chart
digital-look imported chart image
Is NVTA a Buy, Sell or Hold?Get your FREE analysis of NVTA
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Noventa Limited
www.noventa.net

Noventa's strategy is to be the world's largest, low cost industrial scale supplier of tantalum concentrate, a rare speciality metal widely used in the consumer electronics industry.  There is currently a shortage of tantalum supply and stock levels in the industry are being run down. Noventa is in a unique position to expand production to meet the industries needs.

The Jersey based Company's Marropino mine in Mozambique resumed production in April 2010, and the Company has now embarked on a Strategic Plan which it believes will build the foundations of a long-term, profitable, cash generative and sustainable business.

Full Noventa Limited profile here
All RNS Press Releases

RNS Release - Holding(s) in Company

1st Feb 2012, 7:00 am
RNS Number : 5338W
Noventa Limited
01 February 2012
 



 

 

TR-1:          Notifications of Major Interests in Shares

 

1:   Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Noventa Ltd

 

2:    Reason for notification (yes/no)

An acquisition or disposal of voting rights

yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

no

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

no

An event changing the breakdown of voting rights

no

Other (please specify):

 

no

 

3. Full name of person(s) subject to the notification                     

    obligation:

 Standard Life Investments Ltd

4. Full name of shareholder(s) (if different from 3.):

 Vidacos Nominees

5. Date of the transaction (and date on which the threshold 

      is crossed or reached):

30/01/2012

6. Date on which issuer notified:

31/01/2012

7. Threshold(s) that is/are crossed or reached:

6%

 

 

 

 

 

 

 

 

 

 

 

 

8:    Notified Details

A:   Voting rights attached to shares

Class/type of share  If possible use ISIN code

JE00B3YDHF95

 

Situation previous to the triggering transaction

Number of shares

Number of voting rights

7,289,678

7,289,678

 

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Percentage of
voting rights

Direct

Indirect

Direct

Indirect

6,862,355

0

6,862,355

0.000%

5.740%

 

B:   Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date

No. of voting rights that may be acquired
(if the instrument exercised/converted)

Percentage of voting rights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial
instrument

Exercise
price

Expiration
date

Exercise/
Conversion
period

Number of voting
rights instrument
refers to

% of voting rights

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 6,862,355

5.740%

 

 

 

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:


 

Proxy Voting:

 

10. Name of the proxy holder:

 


11. Number of voting rights proxy holder will cease to hold:

 


12. Date on which proxy holder will cease to hold voting rights:

 


 

13. Additional information:

 


14. Contact name:

 

investments_mo@standardlife.com
Standard Life Investments Ltd

15. Contact telephone number:

 

(0131) 245 6565

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBRGDBRGXBGDB

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.